Glosspharyngeal nerve block after adenotensollectomy - Trial PACTR201711002816160
Access comprehensive clinical trial information for PACTR201711002816160 through Pure Global AI's free database. This Not Applicable trial is sponsored by tanta university hospital and is currently Not yet recruiting. The study focuses on Surgery; Other.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
tanta university hospital
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
Postoperative pain is the principal cause of morbidity after tonsillectomy. This pain can affect the patient¿s nutrition, ability to return to work or school, discharge from the hospital, and overall satisfaction with the procedure. Tonsillectomy produces severe pain on the first postoperative day (1). Several techniques have been described for the alleviation of this pain, including the use of opioids (2), steroids (3), and non-steroidal anti-inflammatory drugs (2,4), as well as local anesthetic sprays (5) and infiltration with local anesthetics around the tonsillar bedThere is some controversy regarding the efficacy of glossopharyngeal nerve block (GNB) for the control of immediate posttonsillectomy pain. Some authors have reported that GNB or modified peritonsillar infiltration with local anesthetic are effective for pain associated with tonsillectomy (11¿15). Other reports indicated that GNB with 0.5% bupivacaine or ropivacaine was ineffective for the reduction of early post-tonsillectomy pain in adult and pediatric patients
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201711002816160
Non-Device Trial